王晓杰,教授,博导,担任教育部生物技术、生物工程类教学指导委员会委员,中国医药生物技术学会副理事长。国家科技重大专项首席科学家,长期从事细胞生长因子创新药物及其临床转化研究,主持获得1类新药临床批文5项,成果转化近亿元。主持科技部重大专项项目,国家自然基金、浙江省领雁尖兵计划等课题。以通讯作者在Nature Communications,Advanced Functional Materials等国际期刊发表论文30余篇。获得国家科技进步二等奖(第二),浙江省科技进步一等奖(第一),教育部自然科学一等奖等奖项。获得全国五一劳动奖章(2021)、浙江省杰出教师(2022),浙江省劳动模范(2021)等荣誉称号。
Wang Xiaojie is a professor and doctoral supervisor. She serves as a member of the Teaching Steering Committee for Biotechnology and Bioengineering under the Ministry of Education and as Vice President of the China Society of Pharmaceutical Biotechnology. As Chief Scientist of a National Science and Technology Major Project, she has long focused on the development of innovative drugs based on cell growth factors and their clinical translation. she has led the development of five Class 1 new drugs that have received clinical trial approvals, resulting in technology transfer deals worth nearly 100 million RMB.
5
0
0
| 日期 | 时间 | 会场 | Session | 角色 | 讲题 |
|---|---|---|---|---|---|
| 2026-05-30 | 12:20-12:45 | 分会场9(二层,N215会议室) |
2026年质启新阶・研创致远-临床试验高质量发展培训会暨眼科药物/医疗器械临床试验联盟工作会议 |
讲者 | 一类新药角质细胞生长因子-2滴眼液从基础到临床到成果转化 |